General Summary

The Department of Psychiatry and Behavioral Medicine continues its commitment to actively pursue relevant and essential researches in the field of mental health.  For the year 2008, a total of fourteen researches were made in the fields of biological psychiatry, child and adolescent psychiatry, consultation – liaison psychiatry, social and community psychiatry, and clinical psychiatry.  Four papers were completed while ten are on-going.

            The Department’s Research Committee headed by Dr. Margaret Briones-Querijero conducts regularly research didactics among residents and fellows to facilitate research capability and awareness.   

Research Papers

On-going

Ma. Rosanna E. de Guzman, MD.  A double blind, randomized, placebo controlled trial of Aripirazole plus valproate in the short term and long term treatment of bipolar disorder.

Constantine D. Della, MD, Josefina T. Ly-Uson, MD, and Lorelei Elma-Chua, MD.  A one year multinational, multi-center, randomized, double blind, parallel group, fixed dose, Bifeprunox study combining a 12 week placebo-controlled Quetiapine-referenced with a 12 month Quetiapine-controlled phase in patients with schizophrenia.

Alma L. Jimenez, MD, Joseph P. Anlacan, MD, Evelyn G. Gapuz, MD.  A long term, open label, flexible dose, extension study evaluating the safety and tolerability of LUAA21004 in patients with major depressive disorder.

Marissa B. Pascual, MD, Valerie Heena D. Andora, MD, Felipe P. Jocano Jr., Joselito C. Pascual, MD, Margaret B. Querijero, MD, Eleanor  L. Ronquillo, MD, Antonio C. Sison, MD.  Tagalog concepts of mental health, illness and healing.

Ramona Abat, MD.  The timing of referral of pain patients to liaison psychiatry using the modified self reporting questionnaire.

Anna Garcia-Lantano, MD.  Prevalence of anxiety and depression in patients admitted at the Cancer Institute of UP-PGH.

Carlo Paolo S. Castro, MD.  The effect of the family support group on the impact of illness among caregivers of patients with schizophrenia.

Wilma Anthea M. Chua, MD.  Metabolic syndrome among Filipino schizophrenic patients maintained on typical and atypical antipsychotics consulting at the Out Patient Clinics.

Liecel M. Trinidad-Fulgencio, MD.  The effect of the family support group on the clinical status of patients with schizophrenia.

Joseph Mauro B. Sayo, MD.  The association of PANSS and CGI scores of patients of UP-PGH Psychiatric Ward with hospital readmission.

Completed

Ma. Rosanna E. de Guzman, MD.  An open label prospective trial to explore the tolerability, safety, and efficacy of flexibly dosed paliperidone ER among treatment naïve and newly diagnosed patients with schizophrenia.

Alma L. Jimenez, MD, Joseph P. Anlacan, MD, Evelyn G. Gapuz, MD.  A randomized, double blind parallel group, placebo-controlled, Duloxetine referenced, fixed dose study evaluating the efficacy and safety of three dosages of LUAA21004 in acute treatment of major depressive disorder.

Ma. Cynthia R. Leynes, MD, Tomas D. Bautista, MD.  A randomized, double blind, placebo controlled parallel group study to evaluate the efficacy and safety of flexible dose paliperidone ER in the treatment of subjects with schizoaffective disorder.

Marilou Q. Benignos, MD.  Coping strategies of adolescents with leukemia at Cancer Institute.